Mandy Shipman

Mandy Shipman is a CMC Regulatory Director specializing in biologics and biotechnology, currently working at AstraZeneca. With a PhD in Biochemistry from Cardiff University, they have extensive experience in biopharmaceutical product development, including viral products, gene therapy, and biosimilars. Previously, they held positions as a Senior Quality Assessor at the Medicines and Healthcare products Regulatory Agency and served as Associate Director at Biopharm and Actavis Biologics. Mandy's career spans roles in project management and regulatory science, demonstrating a robust expertise in the biopharmaceutical field.